Clinical Trial Update: Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports completion of a healthy adult volunteer study evaluating two doses of a Shigella vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shigella Infection

Drugs mentioned

• Shigella vaccine

Snippet

Sponsor: Institut Pasteur | Conditions: Shigella Infection | Phase 2 | Status: COMPLETED